Lynk Pharma_Providing professional financial news and data related to Lynk Pharma, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

LYNK PHARMACEUTICALS CO., LTD. Refiles for HKEX Listing with Dual Pipeline of Oral JAK1 Inhibitor and Topical JAK Inhibitor

Tags：

Lynk Pharma IPO refile listing application

2026-06-16

Finance
ALPHAMAB-B (09966.HK): Wu Jiajun appointed CFO
Finance
JINYAN KAOLIN (02693.HK): NEEQ delisting of domestic shares
Finance
TRANSSION (02636.HK): over-allotment option partly exercised
Finance
NEXTEER (01316.HK): board approves up to USD 60m buyback
Tech
ATOMOLOGY: Closes RMB 100 Million-Level Angel Round Co-Led by CIIF and Muhua Kechuang, Targeting Engineered Neutral-Atom Quantum Computing
Research
HK Stock Connect Daily Report: CIG jumps 23.08% to lead gains as Microsoft lobbies White House to drop Chinese optical module ban - 20261111
Research
Hong Kong AI Concept Stock Daily: GIGADEVICE Rises 5.08% to Lead, Z.AI Plans Buyback of Up to HK$4 Billion -20261111
Research
Hong Kong Recently Listed Stocks Daily Report: NEAUTUS Surges 71.64% to Lead the Traditional Chinese Medicine Sector, Telecom Equipment and Semiconductor Chain Strengthen-20261111
Research
HK shares ETFs Daily Report: Value Partners Optical Communication Active ETF Rises 8.39% to Lead for a Second Day as Liquor and Gold Miners Sink — November 11, 2026
Research
NewTimeSpace | Hong Kong Market Close: Three Major Indices Close Lower, Hang Seng Index Falls 0.98%; Hardware Equipment and Semiconductor Themes Strengthen

Scan QR Code

Download App